Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Xbrane Biopharma

8.28 SEK

-0.24 %

Less than 1K followers

XBRANE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xbrane Biopharma

P/E

Median 2019-2025

EV/S

Median 2022-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)490.311,059.981,485.111,163.43141.7120.1010.20
Shares0.81.31.71.92.112.220.6
Market cap387.21,354.92,540.82,258.2298.1245.9210.2
Enterprise value229.31,118.02,290.52,102.5464.2313.3-
EV/S---36.51.91.6-
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.127.5
P/B2.105.265.885.311.741.180.37
P/S---39.21.21.21.4
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio54.4 %55.6 %62.7 %61.5 %26.2 %24.8 %83.5 %
Gearing ratio3.4 %2.4 %10.4 %9.0 %135.1 %91.9 %10.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.